VRXA · Insider Trading
Veraxa Biotech AG Ordinary Shares
Every open-market purchase and sale reported by VRXA officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-29 | Marc Gruninger | Director | Buy | +10,000 | +$9.98K |
| 2026-10-21 | Christoph Samuel Ziegler | Director | Buy | +30,000 | +$32.70K |
| 2026-08-31 | Christoph Rudiger Antz | Chief Executive Officer | Buy | +5,000 | +$7.65K |
| 2026-08-31 | Oliver Rolf Baumann | Director | Buy | +50,000 | +$75.00K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Oliver Rolf Baumann | Director | 5,773,618 | $6.41M |
| Christoph Samuel Ziegler | Director | 37,932 | $42.10K |
| Christoph Rudiger Antz | Chief Executive Officer | 5,000 | $5.55K |
| Marc Gruninger | Director | 867 | $962 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VRXA quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.